GL1X · GenesisL1 explorer

MolNFT v1 · #83343 · protein

Crystal structure of S6K1 kinase domain in complex with a quinoline derivative 1-oxo-1-[(4-SULFAMOYLPHENYL)AMINO]PROPAN-2-yl-2-methyl-1, 2,3,4-tetrahydroacridine-9-carboxylate

3WF9 · Ribosomal protein S6 kinase beta-1: “Crystal structure of S6K1 kinase domain in complex with a quinoline derivative…”. X-ray diffraction, 2 ligands (FS7, ZN), 1 pocket (best druggability 0.75). MolNFT v1 #83343 on GenesisL1: 3D…

PDB
3WF9
Type
protein
Length
288 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Ribosomal protein S6 kinase beta-1
EC
2.7.11.1
UniProt
P23443
Ligands
FS7, ZN
Pockets
1 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARibosomal protein S6 kinase beta-1 (EC 2.7.11.1)protein28838% helix, 16% strandP23443

Ligands and binding sites

  • FS7 · (2S)-1-oxo-1-[(4-sulfamoylphenyl)amino]propan-2-yl (2S)-2-methyl-1,2,3,4-tetrahydroacridine-9-carboxylate · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15190.750.8363FS7

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 3WF9 · Crystal structure of S6K1 kinase domain in complex with a quinoline derivative… · the same entry in another collection · chain A against A, TM-score 1.00
  • P23443 · AlphaFold monomer V2.0 prediction for ribosomal protein S6 kinase beta-1 (P23443) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.